Skip to main content
Strategic Partners A/S logo

Strategic Partners A/S — Investor Relations & Filings

Ticker · STRAP ISIN · DK0062502894 LEI · 54930025OZD2GGSQ7L42 CO Financial and insurance activities
Open in API
Filings indexed 501 across all filing types
Latest filing 2020-02-07 Transaction in Own Shar…
Country DK Denmark
Listing CO STRAP

About Strategic Partners A/S

https://www.strategic-partners.dk/

Strategic Partners A/S is an investment company that engages in strategic partnerships with businesses that have significant potential. The company's strategy involves taking an active ownership role to create value through its competencies. In addition to its primary focus, the firm may also invest in other equity interests and properties to generate returns. Formerly known as Orphazyme A/S, the company sold its biotechnology activities in May 2022. A new board and management team was appointed in May 2023, and the company officially adopted its new strategy, purpose, and name in October 2024.

Recent filings

Filing Released Lang Actions
Announcement of treasury shares
Transaction in Own Shares Classification · 95% confidence The document is a short announcement (under 5,000 characters) from Orphazyme A/S regarding the status of its treasury shares following a private placement. It explicitly mentions that the company no longer holds any treasury shares. While it relates to share capital, it is a specific notification of a change in treasury share holdings, which falls under the category of 'Transaction in Own Shares' (POS).
2020-02-07 English
Share Issue/Capital Change 2020
Share Issue/Capital Change Classification · 99% confidence The document is a short company announcement dated February 7, 2020, titled "Announcement of treasury shares." It explicitly states that following a completed offering of new shares, Orphazyme "as of today no longer holds any treasury shares." This directly relates to the company's own share transactions (repurchase or issuance). This fits the definition of 'Transaction in Own Shares' (POS). It is not a comprehensive report (10-K, IR), an earnings release (ER), or a general regulatory filing (RNS), but a specific announcement about its own stock holdings.
2020-02-07 English
Orphazyme completes offering of 7,032,937 shares in a directed issue and private placement and raises approximately DKK 745,000,000 (EUR 100 million/USD 110 million)
Share Issue/Capital Change Classification · 100% confidence The document is a formal company announcement from Orphazyme A/S detailing the completion of a directed share issue and private placement, which raised approximately DKK 745 million. It covers the number of shares issued, the offer price, the impact on share capital, and the expected timetable for listing. This falls squarely under the definition of a 'Share Issue/Capital Change' (SHA) as it describes the issuance of new shares and the resulting change in the company's capital structure.
2020-02-07 English
Capital/Financing Update 2020
Capital/Financing Update Classification · 98% confidence The document is a 'Company announcement' from Orphazyme A/S detailing the completion of an offering of new and existing shares, raising significant gross proceeds (DKK 745,000,000). This activity directly relates to the company's capital structure, fundraising, and issuance of shares. This aligns perfectly with the definition of 'Capital/Financing Update' (CAP). While it involves shares, it is a financing event rather than just a report of buying back own shares (POS) or a general share issue announcement (SHA), as the primary focus is the successful capital raise via placement. Since it is a specific announcement about fundraising/capital structure change, CAP is the most precise fit over the general 'SHA' or the fallback 'RNS'. The document length is substantial (14,812 chars), indicating it is the primary announcement, not just a brief notice of publication.
2020-02-07 English
Announcement of treasury shares
Transaction in Own Shares Classification · 100% confidence The document is a short company announcement from Orphazyme A/S regarding the number of treasury shares held by the company. It explicitly mentions the total number of treasury shares and the percentage of share capital they represent, which is a standard disclosure for share buybacks or treasury share updates. This falls under the category of 'Transaction in Own Shares' (POS).
2020-02-06 English
Transaction in Own Shares 2020
Transaction in Own Shares Classification · 99% confidence The document is a short company announcement titled "Announcement of treasury shares." It explicitly states the number of treasury shares held by the company (3,071,673) and the corresponding percentage of total share capital (15.35%), referencing Section 31 of the Danish Capital Markets Act. This action—reporting on the company's own shares held in treasury—falls directly under the definition of transactions involving the company's own stock, which aligns best with the 'Transaction in Own Shares' category (POS). It is not a general financing update (CAP) or a director's dealing (DIRS). Given the specific nature of reporting treasury share holdings, POS is the most accurate classification.
2020-02-06 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.